16-Apr-2026
Top mid to large cap U.S. homebuilding stocks by Quant rating as builder sentiment falls
Seeking Alpha News (Wed, 15-Apr 2:47 PM ET)
PRNewswire (Tue, 31-Mar 12:00 PM ET)
Taylor Morrison Announces Date for First Quarter 2026 Earnings Release and Webcast Conference Call
PRNewswire (Wed, 25-Mar 6:55 AM ET)
Taylor Morrison Celebrates Women in Construction Week by Spotlighting Team Members
PRNewswire (Thu, 5-Mar 6:03 AM ET)
National Homebuilder Swaps Picture Perfect for Real Life
PRNewswire (Wed, 18-Feb 6:03 AM ET)
Taylor Morrison Reports Fourth Quarter and Full Year 2025 Results
PRNewswire (Wed, 11-Feb 6:15 AM ET)
Taylor Morrison Recognized on Fortune's 2026 World's Most Admired Companies List
PRNewswire (Tue, 3-Feb 6:02 AM ET)
Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds, and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West, and Financial Services. The majority of the company's revenue is derived from its West Segment.
Taylor Morrison Home trades on the NYSE stock market under the symbol TMHC.
As of April 16, 2026, TMHC stock price declined to $57.39 with 1,238,609 million shares trading.
TMHC has a beta of 0.55, meaning it tends to be less sensitive to market movements. TMHC has a correlation of 0.08 to the broad based SPY ETF.
TMHC has a market cap of $5.53 billion. This is considered a Mid Cap stock.
Last quarter Taylor Morrison Home reported $2 billion in Revenue and $1.91 earnings per share. This beat revenue expectation by $153 million and exceeded earnings estimates by $.18.
In the last 3 years, TMHC traded as high as $75.49 and as low as $37.23.
The top ETF exchange traded funds that TMHC belongs to (by Net Assets): IJH, VTI, IWM, VB, AVUV.
TMHC has underperformed the market in the last year with a price return of +3.3% while the SPY ETF gained +31.9%. TMHC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.5% and -1.6%, respectively, while the SPY returned +1.6% and +7.1%, respectively.
TMHC support price is $56.40 and resistance is $59.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TMHC shares will trade within this expected range on the day.